Nanoparticle Dispersions & Drug Nanocrystals

Drug-containing nanoparticles offer the potential for both increased dissolution rate and higher drug activity compared to bulk crystalline drug. These advantages can improve oral bioavailability of drugs for which absorption is either dissolution-rate-limited or solubility-limited. This webinar explores the physicochemical properties, in vitro and in vivo performance, and manufacturing considerations for amorphous nanoparticle dispersions and drug nanocrystals for bioavailability enhancement, presenting a range of formulation technologies and case studies demonstrating effectiveness.